StockNews.com Upgrades Rockwell Medical (NASDAQ:RMTI) to “Buy”

Rockwell Medical (NASDAQ:RMTI) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday.

Other analysts have also issued reports about the stock. Rodman & Renshaw began coverage on shares of Rockwell Medical in a research note on Thursday, November 14th. They issued a “buy” rating and a $5.00 price target for the company. HC Wainwright lowered their price target on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, November 25th. Finally, RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th.

Rockwell Medical Stock Performance

Shares of NASDAQ RMTI traded up $0.03 during midday trading on Thursday, reaching $2.07. 464,217 shares of the company traded hands, compared to its average volume of 391,746. The company has a market cap of $66.90 million, a price-to-earnings ratio of -41.40 and a beta of 1.38. The stock has a 50-day moving average price of $3.06 and a 200 day moving average price of $2.68. Rockwell Medical has a 52 week low of $1.16 and a 52 week high of $5.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00.

Institutional Trading of Rockwell Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Concurrent Investment Advisors LLC acquired a new position in Rockwell Medical in the third quarter worth approximately $40,000. Verus Capital Partners LLC acquired a new position in shares of Rockwell Medical in the 3rd quarter worth $51,000. Barclays PLC acquired a new stake in shares of Rockwell Medical during the third quarter worth $90,000. Beacon Financial Advisory LLC acquired a new stake in shares of Rockwell Medical during the third quarter worth $98,000. Finally, XTX Topco Ltd boosted its position in shares of Rockwell Medical by 45.7% in the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock valued at $113,000 after purchasing an additional 8,922 shares during the period. 23.31% of the stock is owned by institutional investors and hedge funds.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.